improvements
-
Alzheimer’s & Dementia Care
Real-World BEACON Study Highlights Zunveyl’s Potential in Long-Term Alzheimer’s Care with Provider-Reported Improvements.
Top-line data emerging from the BEACON study, a real-world investigation into the therapeutic performance of Zunveyl (benzgalantamine), indicate a positive…
Read More » -
Alzheimer’s & Dementia Care
Zunveyl Associated with Provider-Reported Improvements in Alzheimer’s Patients in Real-World Long-Term Care Study
Top-line data from the BEACON study, a real-world observational investigation, indicate that Zunveyl (benzgalantamine) was associated with significant provider-reported improvements…
Read More »
